Recent reporting reveals that Elon Musk’s deep involvement in politics—most notably his alliance with President Trump—coincided with a period of intensified drug use and personal instability. Musk donated roughly $275 million to Trump’s campaign and became a prominent figure in the administration, yet behind the scenes, his behavior raised concerns among colleagues and former friends.
According to sources and private communications, Musk’s drug use extended well beyond prescribed ketamine for depression. He reportedly consumed ketamine frequently, sometimes daily, and mixed it with substances like Ecstasy and psychedelic mushrooms. His erratic conduct, including public outbursts and controversial gestures, fueled speculation about his fitness for a role in government. Though Musk denied drug use publicly and dismissed media coverage, insiders described a pattern of mood swings, binge eating, and obsessive behavior.
His personal life has also grown increasingly complex. Musk is engaged in custody disputes with multiple partners, including musician Claire Boucher (Grimes), who has raised concerns about their son’s exposure to high-profile political events. Another former partner, Ashley St. Clair, revealed the existence of Musk’s 14th child and described legal efforts to silence her.
Despite his public image as a visionary entrepreneur, Musk’s conduct has prompted scrutiny from business associates and government officials. SpaceX, a major federal contractor, enforces drug-free policies, yet Musk reportedly received advance notice of employee drug tests. His departure from government this week suggests a shift in priorities, though questions remain about the implications of his behavior for both his companies and political influence.
